We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128B
AUM Growth
+$15.2B
Cap. Flow
+$9.11B
Cap. Flow %
7.13%
Top 10 Hldgs %
13.82%
Holding
11,531
New
1,109
Increased
4,588
Reduced
4,144
Closed
1,087

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.71B
2
APA icon
APA Corp
APA
+$435M
3
FDO
FAMILY DOLLAR STORES
FDO
+$369M
4
WYNN icon
Wynn Resorts
WYNN
+$334M
5
HRI icon
Herc Holdings
HRI
+$313M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$755M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$344M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$287M
4
AAPL icon
Apple
AAPL
+$281M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$242M

Sector Composition

Rank Sector Weight
1 Energy 8.83%
2 Technology 6.7%
3 Healthcare 6.28%
4 Financials 6.28%
5 Industrials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBBK icon
10151
The Bancorp
TBBK
$2.79B
$1K ﹤0.01%
49
-27,268
-100% -$424K
TOPS icon
10152
TOP Ships
TOPS
$4.32M
– –
0
– –
TRUE
10153
DELISTED
TrueCar
TRUE
$1K ﹤0.01%
+100
New +$1.22K
UAMY icon
10154
CALL
United States Antimony
UAMY
$766M
$1K ﹤0.01%
+500
New +$910
WNC icon
10155
PUT
Wabash National
WNC
$543M
$1K ﹤0.01%
100
– –
WVVI icon
10156
Willamette Valley Vineyards
WVVI
$13.5M
$1K ﹤0.01%
100
– –
TRAW icon
10157
CALL
Traws Pharma
TRAW
$7.43M
– –
0
– –
TEN
10158
CALL
Tsakos Energy Navigation Ltd
TEN
$1.19B
$1K ﹤0.01%
40
-340
-89% -$12.3K
ALIM
10159
CALL
DELISTED
Alimera Sciences
ALIM
$1K ﹤0.01%
+7
New +$622
YTEN
10160
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
– –
0
– –
BKCC
10161
PUT
DELISTED
BlackRock Capital Investment Corporation
BKCC
$1K ﹤0.01%
100
-900
-90% -$7.97K
FGH
10162
DELISTED
FG Group Holdings Inc.
FGH
$1K ﹤0.01%
250
-876
-78% -$3.84K
CYAN
10163
DELISTED
Cyanotech Corp
CYAN
$1K ﹤0.01%
+276
New +$1.35K
MARK
10164
DELISTED
Remark Holdings, Inc.
MARK
$1K ﹤0.01%
7
– –
IMGN
10165
CALL
DELISTED
Immunogen Inc
IMGN
$1K ﹤0.01%
100
-1,500
-94% -$18.8K
INFI
10166
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1K ﹤0.01%
100
– –
ACGN
10167
PUT
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
+4
New +$1.65K
KSPN
10168
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$1K ﹤0.01%
+7
New +$479
AGRX
10169
DELISTED
Agile Therapeutics
AGRX
– –
0
– –
STAB
10170
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$1K ﹤0.01%
140
– –
RADA
10171
DELISTED
Rada Electronic Industries Ltd
RADA
$1K ﹤0.01%
400
+220
+122% +$642
ADXS
10172
DELISTED
Advaxis Inc
ADXS
$1K ﹤0.01%
21
– –
FLGE
10173
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
$1K ﹤0.01%
+10
New +$997
RNET
10174
DELISTED
RigNet, Inc.
RNET
$1K ﹤0.01%
21
-468
-96% -$23.4K
SYNC
10175
CALL
DELISTED
Synacor, Inc.
SYNC
$1K ﹤0.01%
200
-400
-67% -$952
405 406
407
408 409

Similar funds

MCM
Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return
STC
SEI Trust Company Oaks, Pennsylvania $10.3B AUM 18.76% 1-Year Est. Return
1IC
1919 Investment Counsel Baltimore, Maryland $4.86B AUM 17.56% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return
BCMU
BlueCrest Capital Management (UK) St. Peter Port, Guernsey $2.66B AUM 11.87% 1-Year Est. Return
MWR
McAdams Wright Ragen Seattle, Washington $1.79B AUM 13.95% 1-Year Est. Return
MGC
Merchants' Gate Capital New York $1.27B AUM 15.57% 1-Year Est. Return
BP
Banyan Partners Palm Beach Gardens, Florida $1.18B AUM 16.95% 1-Year Est. Return

UBS's Q2 2014 Portfolio in Review

As of Q2 2014, UBS held 11,531 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $9.11B of net new capital in Q2 2014, opening 1,109 new positions and adding to 4,588 existing holdings. Its largest new stake was JD.com: 3,966,156 shares worth $113M.

By sector, the portfolio is most concentrated in Energy at 8.8% of assets, down from 9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baker Hughes, an estimated $755M trimmed.

  • UBS's largest Q2 2014 buy was JD.com: 3,966,156 shares worth $113M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $1.71B increase.
  • UBS's biggest Q2 2014 reduction was Baker Hughes, cutting an estimated $755M.
  • UBS fully exited KKR FINANCIAL HOLDINGS LLC COM in Q2 2014, selling an estimated $47.8M.
  • UBS's ten largest holdings make up 14% of its $128B portfolio in Q2 2014.
  • UBS opened 1,109 new positions and closed 1,087 in Q2 2014.
  • UBS's portfolio value rose 14% quarter-over-quarter to $128B.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.